Skip to main content

TC BioPharm (Holdings) plc

TCBPDelisted Aug 8, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001872812

TC BioPharm (Holdings) plc was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Jan 11, 2023; 12 institutions reported holding it in 13F filings for Q3 2023, worth $179.6K in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding TC BioPharm (Holdings) plc changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of TCBP: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders85−3
Shares279.1K451.4K+172.3K (+61.7%)
Value$399.0K$166.0K−$233.0K (−58.4%)

New holders (4)

Institutions that held TC BioPharm (Holdings) plc at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to TCBP in Q2 2022
InstitutionSharesValue% of portfolio
Legal & General Group Plc207,258$76.0K0.00%
KCL Capital, L.P.100,000$37.0K0.02%
Warberg Asset Management LLC99,165$36.0K0.01%
Renaissance Technologies LLC21,475$8.00K0.00%

Sold out (7)

Institutions that held TC BioPharm (Holdings) plc at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of TCBP in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Kepos Capital LP184,757$264.0K
Citadel Advisors LLC22,379$32.0K
Two Sigma Securities, LLC20,859$30.0K
Susquehanna International Group, LLP17,305$25.0K
Jane Street Group, LLC15,688$22.0K
UBS Group AG1,191$2.00K
Citigroup Inc600$1.00K